Loading...

Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. Genta has built a broad portfolio of proprietary products in various stages of clinical development. The Company’s drugs include Ganite® (gallium nitrate injection), Genasense® (oblimersen sodium) injection, tesetaxel, and oral gallium. Genta is committed to developing innovative products to better the lives of people with cancer.   Learn More

Loading...
home-callout-1-top
Leadership in Cancer Drug Development

Genta's team has extensive drug development and commercialization experience.

Read More
Loading...
home-callout-2
Oncology Focused Pipeline

Genasense® (oblimersen sodium) Injection inhibits the production of a protein known as Bcl-2. 

Read More

Click to view the Bcl-2 Mechanism of Action Video

video-preview-btn

  • January 12, 2010
    Two New Studies Show Gallium-Containing Compounds Significantly Increase Bone Strength in Standard Models of Osteoporosis
    Read More
  • December 2, 2009
    Genta to Support Initiation of New Clinical Trial using Ganite® as Treatment for Life-Threatening Infections in Patients with Cystic Fibrosis
    Read More
  • 12th Annual BIO CEO & Investor Conference

    2010-02-08
    New York, NY
  • 3rd Oligonucleotide-based Therapeutics Conference

    2010-03-23
    Bethesda, MD
  • AACR (American Association for Cancer Research) 10th annual meeting

    2010-04-17
    Washington, DC
  • American Society of Clinical Oncology (ASCO)

    2010-06-04
    Chicago, IL